AlpInvest Partners B.V. - AIMMUNE THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 156 filers reported holding AIMMUNE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.

Links
Filings
External links
Quarter-by-quarter ownership
AlpInvest Partners B.V. ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$1,062,000
+1.4%
38,9430.0%2.27%
-48.0%
Q2 2018$1,047,000
-15.6%
38,9430.0%4.37%
-60.9%
Q1 2018$1,240,000
-36.3%
38,943
-24.4%
11.17%
+60.8%
Q4 2017$1,948,000–51,498–6.95%–
 Download
Other shareholders

There were no reported owners of AIMMUNE THERAPEUTICS INC in Q1 2018.

NameSharesValueWeighting ↓
View complete list of AIMMUNE THERAPEUTICS INC shareholders